Skip to content

The effect of adding Dexamethasone to Bupivacaine in ilioinguinal and iliohypogastric nerves block on pain after inguinal hernia surgery

The effect of adding Dexamethasone to Bupivacaine in ilioinguinal and iliohypogastric nerves block on pain after inguinal hernia surgery with spinal anesthesia

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2017012425676N6
Enrollment
44
Registered
2017-02-19
Start date
2016-01-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inguinal hernia. Unilateral or unspecified inguinal hernia, without obstruction or gangrene

Interventions

Intervention 1: At the end of surgery, all patients will be underwent ilioinguinal and iliohypogastric block and, 2 cc Bupivacaine 0.5% plus 1 cc (4 mg) Dexamethasone directly will be injected aroun
Prevention
At the end of surgery, all patients will be underwent ilioinguinal and iliohypogastric block and, 2 cc Bupivacaine 0.5% plus 1 cc (4 mg) Dexamethasone directly will be injected around nerves tissues
At the end of surgery, all patients will be underwent ilioinguinal and iliohypogastric block and 2 cc Bupivacaine 0.5% plus 1 cc normal saline directly will be injected around nerves tissues.

Sponsors

Vice Chancellor for Research of Qazvin University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 80 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: patients aged 20 to 45 years; candidate for elective unilateral inguinal hernia surgery; ASA class 1 or 2. Exclusion criteria: The reluctance of patients; opioid addiction; analgesic consumption during the past 24 hours; surgery time more than 1 hour and half; being spinal anesthesia off during surgery; patients needing mesh to repair and having both ilioinguinal & iliohypogastric nerves injury during surgery.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Pain. Timepoint: At 1, 2, 4, 12 and 24 hours after surgery. Method of measurement: Score of Pain according to visual analog scale.;Amount of analgesic consumption. Timepoint: At 1, 2, 4, 12 and 24 hours after surgery. Method of measurement: Total dose of administered pethidine or Diclofenac.;First time of feeling pain. Timepoint: At 1, 2, 4, 12 and 24 hours after surgery. Method of measurement: Patient file.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Hamid Kayalha

Qazvin University of Medical Sciences

h_kayalha @ yahoo.com+98 28 3332 0105

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026